alexa Jyothy John | Texas Southern University
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Jyothy John

Jyothy John Jyothy John
Department of Pharmaceutical Sciences
Texas Southern University

Currently Dr. Jyothy John is a bioequivalence reviewer at US Food and Drug Administration. (USFDA). Jyothy received her B.S. in Pharmacy and M.S. in Pharmaceutics from Rajiv Gandhi University of Health Sciences, Bangalore, India. She earned her Ph.D. in Pharmaceutical Sciences from College of Pharmacy & Health Sciences, Texas Southern University (TSU), Houston, TX. Her Ph.D. study focused on ‘Effect of drug-drug and drug-herbal interactions on the pharmacokinetics and pharmacodynamics of warfarin". Jyothy's research work has been published in several journals, including the Journal of Bioequivalence & Bioavailability, British Journal of Pharmacology, Journal of Chromatography B, International Journal of Nanomedicine and a book chapter in Intech Open Access. She is a co-inventor of two U.S. patents on pharmaceutical formulations. She then pursued post-doctoral training on an NIH funded project entitled “Development of a Novel Nanoconstruct Based Photothermal Therapy for Tumor Hypoxia” at the Department of Pharmaceutical Sciences at TSU in collaboration with University of Texas at M.D. Anderson Cancer Center, Houston, TX. Jyothy is a registered pharmacist (RPh) and has taught both PharmD and PhD courses at the College of Pharmacy at TSU.

Research Interest

In-vivo bioequivalence studies (both clinical and pre-clinical), Formulation of pharmaceutical drug products to increase the bioavailability, Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method development and validation studies, DIssolution studies, Differential Scanning Calorimetry studies, Zeta Sizer studies, UV-VIS Spectrophotometer studies, Fluorescence Spectrophotometer studies, HPLC-UV, and UPLC studies.



Oral Liquid Formulation of Etravirine for Enhanced Bioavailability
Jyothy John and Dong Liang
Review Article: J Bioequiv Availab
DOI: 10.4172/jbb.1000179
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version